Stockreport

RenovoRx advances RenovoCath adoption at U.S. cancer centers [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF These 12 centers are in addition to those centers currently using RenovoCath as part of RenovoRx's ongoing Phase III trial. A total of 33 centers have requested access t [Read more]